发明名称 |
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION |
摘要 |
Ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided suitable for intravitreal administration to the eye. The ophthalmic formulations include a stable liquid formulation and a lyophilizable formulation. Preferably, the protein antagonist has the amino acid sequence shown in SEQ ID NO:4. A pre-filled syringe is provided which is suitable for intravitreal administration comprising a stable ophthalmic formulation of a vascular endothelial growth factor (VEGF) antagonist. |
申请公布号 |
EP2944306(A1) |
申请公布日期 |
2015.11.18 |
申请号 |
EP20150169936 |
申请日期 |
2007.06.14 |
申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
GRAHAM, KENNETH S.;FRYE, KELLY;FURFINE, ERIC;DIX, DANIEL |
分类号 |
A61K9/00;A61K9/19;A61K38/00;A61K38/17;A61M5/178;C07K14/47 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|